Testing C1-inhibitor for brain bleed after aneurysm
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a drug called C1-inhibitor (a protein that calms inflammation) given shortly after a bleeding stroke caused by an aneurysm. The goal is to see if it can reduce brain damage and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed brain bleed from a burst aneurysm, seen on a CT scan.
- You are 18 years or older.
- Your condition is rated WFNS grade 1 to 5 (which covers all severity levels from mild to severe).
- You are not in another experimental treatment study.
- You are not expected to die within 24 hours of arriving at the hospital.
- You are not pregnant, and you have no known blood clotting disorder, allergy to blood products or C1-inhibitor, or hereditary complement deficiency.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a spinal fluid (CSF) treatment to help prevent dangerous blood-vessel tightening (vasospasm) after a type of brain bleed caused by an aneurysm. If you qualify, the goal is to reduce complications soon after aneurysm repair.
This trial uses brain MRI scans and memory/brain-function tests in people who are recovering from a specific type of brain bleed (aneurysmal subarachnoid hemorrhage). It aims to understand how the brain’s memory area changes after the event and how that may relate to memory function during rehabilitation.
This trial tests whether giving a statin medication very early (within 6 hours of symptoms) can improve recovery after a brain aneurysm bleed. It aims to see if early treatment helps protect the brain.
This trial tests whether the drug cilostazol can prevent delayed brain damage in people who have had bleeding from a brain aneurysm. It is for adults who had their aneurysm treated within 72 hours and are in moderate to serious condition.
This trial tests whether a drug called cerebrolysin can help people who have a bleeding stroke in the outer part of the brain (lobar hemorrhage). It looks at safety and how well it works.
This trial tests whether placing a small drain in the lower back and giving a clot-dissolving medicine (urokinase) into the fluid around the brain can help people recover from a severe bleeding stroke caused by a brain aneurysm. It is for patients who are treated quickly after the bleed.
Hear when a new Subarachnoid Hemorrhage, Aneurysmal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.